Epilepsy

Overview

Epilepsy is a chronic neurological disorder characterized by recurrent unprovoked seizures, affecting ~50 million people worldwide. Approximately 30% of patients have drug-resistant epilepsy — a population where microbiome-targeted interventions (particularly the ketogenic diet) have shown the most clinical impact.

The gut microbiome's role in epilepsy operates through the gut brain axis: microbially-derived neuroactive metabolites (kynurenine pathway products, GABA, serotonin, SCFAs) directly modulate neuronal excitability and seizure thresholds.

Microbiome Associations

Cerebral Palsy-Epilepsy Comorbidity

Children with cerebral palsy plus epilepsy (CP+E) have distinct gut microbiota compared to CP without epilepsy, suggesting epilepsy is not merely a neurological overlay but involves gut-brain axis restructuring ^[1], ^[2].

Causal Evidence (Mendelian Randomization)

MR supports a causal link between specific gut microbiota and epilepsy risk, though the specific taxa remain under investigation ^[3].

Kynurenine Pathway

The kynurenine pathway produces metabolites with opposing neurological effects:

• Kynurenic acid (KA): Neuroprotective NMDA antagonist; may raise seizure threshold.
• Quinolinic acid (QUIN): Neurotoxic NMDA agonist; may lower seizure threshold.
• The KA/QUIN balance, modulated by gut microbiome composition and inflammation, may influence seizure susceptibility.

Ketogenic Diet and the Microbiome

The ketogenic diet is the most evidence-based microbiome-modulating intervention for drug-resistant epilepsy:

• Dramatically reshapes gut microbiome composition within days.
• Increases akkermansia muciniphila and decreases enterobacteriaceae in animal models.
• Produces ketone bodies (BHB) that have anti-inflammatory and neuroprotective effects, including tlr4 inhibition.
• The microbiome changes may be causally required for the anti-seizure effect: antibiotic ablation of the microbiome eliminated ketogenic diet efficacy in mice ^[4].

Cross-References

• cerebral palsy — Primary comorbidity; shared gut-brain axis disruption
• gut brain axis — Mechanism connecting gut microbiome to seizure susceptibility
• kynurenine — Neuroactive metabolites modulating excitability
• ketogenic diet — Microbiome-mediated anti-seizure intervention
• akkermansia muciniphila — Enriched by ketogenic diet
• autism spectrum disorder — Epilepsy comorbidity in ASD (~30%)
• depression — Bidirectional epilepsy-depression relationship